NewslettersCancer Stem Cell NewsHematopoiesis News A Novel CD34-Specific T Cell Engager Efficiently Depletes Acute Myeloid Leukemia and Leukemic Stem Cells In Vitro and In Vivo By lbeveridge - August 1, 2022 0 To target drug-resistant primitive leukemic cells better, scientists designed a CD34/CD3 bi-specific T-cell engager and characterized its anti-leukemia potential in vitro, ex vivo and in vivo. [Haematologica] Full Article